LeMaitre Vascular - 19 Year Stock Price History | LMAT
- The all-time high LeMaitre Vascular stock closing price was 107.45 on November 22, 2024.
- The LeMaitre Vascular 52-week high stock price is 109.58, which is 27.5% above the current share price.
- The LeMaitre Vascular 52-week low stock price is 71.42, which is 16.9% below the current share price.
- The average LeMaitre Vascular stock price for the last 52 weeks is 89.60.
LeMaitre Vascular Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 89.6306 | 91.0257 | 103.4950 | 77.7023 | 85.9600 | -6.25% |
2024 | 79.0773 | 55.9865 | 107.4460 | 53.3110 | 91.6925 | 63.63% |
2023 | 54.3200 | 44.3955 | 66.9937 | 43.7115 | 56.0358 | 24.60% |
2022 | 45.2929 | 49.7960 | 54.4342 | 37.8556 | 44.9721 | -7.40% |
2021 | 50.1260 | 38.5253 | 60.9869 | 38.5253 | 48.5680 | 25.10% |
2020 | 29.2687 | 33.8852 | 39.5605 | 19.9717 | 38.8224 | 14.09% |
2019 | 28.5137 | 21.8952 | 34.2732 | 21.0153 | 34.0271 | 53.76% |
2018 | 31.1032 | 28.8885 | 38.1510 | 20.6034 | 22.1293 | -25.13% |
2017 | 27.9311 | 23.2497 | 36.2660 | 20.1811 | 29.5569 | 26.58% |
2016 | 15.9075 | 14.4246 | 23.4616 | 11.3974 | 23.3510 | 48.46% |
2015 | 10.2383 | 7.0267 | 16.2026 | 6.5504 | 15.7285 | 128.81% |
2014 | 6.7656 | 7.0579 | 7.4670 | 5.9012 | 6.8739 | -2.73% |
2013 | 5.8985 | 4.9932 | 7.6049 | 4.9932 | 7.0667 | 42.02% |
2012 | 5.0709 | 4.8916 | 5.6347 | 4.2805 | 4.9758 | -1.37% |
2011 | 5.6031 | 5.8413 | 6.3496 | 4.4996 | 5.0450 | -11.46% |
2010 | 4.8355 | 4.1916 | 6.1275 | 3.7203 | 5.6983 | 35.40% |
2009 | 2.7768 | 1.8012 | 4.2085 | 1.6076 | 4.2085 | 116.64% |
2008 | 3.0232 | 5.0502 | 5.6478 | 1.5655 | 1.9426 | -62.77% |
2007 | 5.4532 | 5.0922 | 6.4390 | 4.6798 | 5.2185 | 3.33% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $1.915B | $0.220B |
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $234.530B | 28.20 |
Boston Scientific (BSX) | United States | $156.881B | 39.27 |
Stryker (SYK) | United States | $150.466B | 31.46 |
EssilorLuxottica (ESLOY) | France | $133.537B | 0.00 |
Medtronic (MDT) | Ireland | $110.863B | 16.19 |
Lonza Group Ag (LZAGY) | Switzerland | $49.634B | 0.00 |
Haleon (HLN) | United Kingdom | $48.673B | 27.69 |
ResMed (RMD) | United States | $36.905B | 27.72 |
GE HealthCare Technologies (GEHC) | United States | $33.485B | 15.90 |
Agilent Technologies (A) | United States | $32.436B | 21.43 |
Terumo (TRUMY) | Japan | $27.642B | 35.90 |
Insulet (PODD) | United States | $22.854B | 89.71 |
Koninklijke Philips (PHG) | Netherlands | $22.587B | 16.24 |
Zimmer Biomet Holdings (ZBH) | United States | $19.181B | 12.32 |
Baxter (BAX) | United States | $16.247B | 12.13 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.648B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
Demant (WILYY) | Denmark | $8.231B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.767B | 23.55 |
Lantheus Holdings (LNTH) | United States | $5.621B | 14.18 |
Prestige Consumer Healthcare (PBH) | United States | $4.402B | 19.67 |
Perrigo (PRGO) | Ireland | $3.719B | 9.43 |
Haemonetics (HAE) | United States | $3.532B | 15.39 |
ICU Medical (ICUI) | United States | $3.480B | 25.66 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.097B | 25.73 |
QuidelOrtho (QDEL) | United States | $2.263B | 15.56 |
GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
AtriCure (ATRC) | United States | $1.619B | 0.00 |
Neogen (NEOG) | United States | $1.435B | 18.36 |
Kestra Medical Technologies (KMTS) | United States | $1.264B | 0.00 |
AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
Green Thumb Industries (GTBIF) | United States | $1.182B | 26.59 |
BioLife Solutions (BLFS) | United States | $1.121B | 0.00 |
InMode (INMD) | Israel | $1.020B | 9.34 |
Phibro Animal Health (PAHC) | United States | $0.973B | 12.44 |
CeriBell (CBLL) | United States | $0.649B | 0.00 |
Evolus (EOLS) | United States | $0.625B | 0.00 |
Owens & Minor (OMI) | United States | $0.570B | 4.73 |
Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.535B | 0.00 |
Valneva SE (VALN) | France | $0.524B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.498B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.431B | 0.00 |
Surmodics (SRDX) | United States | $0.409B | 0.00 |
SNDL (SNDL) | Canada | $0.355B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.335B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.321B | 0.00 |
Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.288B | 51.30 |
Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.267B | 22.53 |
Cerus (CERS) | United States | $0.254B | 0.00 |
ZimVie (ZIMV) | United States | $0.251B | 11.40 |
Verano Holdings (VRNOF) | United States | $0.235B | 0.00 |
Biote (BTMD) | United States | $0.224B | 6.31 |
High Tide (HITI) | Canada | $0.191B | 0.00 |
Omeros (OMER) | United States | $0.188B | 0.00 |
Brainsway (BWAY) | Israel | $0.187B | 49.55 |
Quanterix (QTRX) | United States | $0.186B | 0.00 |
Organigram Global (OGI) | Canada | $0.182B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.182B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.179B | 14.58 |
TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
FitLife Brands (FTLF) | United States | $0.128B | 0.00 |
Exagen (XGN) | United States | $0.128B | 0.00 |
Jin Medical (ZJYL) | China | $0.125B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
Agape ATP (ATPC) | $0.103B | 0.00 | |
MacroGenics (MGNX) | United States | $0.100B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
Fonar (FONR) | United States | $0.080B | 10.32 |
Veru (VERU) | United States | $0.076B | 0.00 |
Zynex (ZYXI) | United States | $0.075B | 0.00 |
InterCure (INCR) | Israel | $0.069B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.061B | 0.00 |
United Health Products (UEEC) | United States | $0.061B | 0.00 |
Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
Apyx Medical (APYX) | United States | $0.054B | 0.00 |
ImmuCell (ICCC) | United States | $0.048B | 0.00 |
Modular Medical (MODD) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.039B | 13.35 |
Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
Safety Shot (SHOT) | United States | $0.031B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 30.86 |
INLIF (INLF) | $0.018B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
Senestech (SNES) | United States | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |